The global pandemics of plague and smallpox in the Middle Ages claimed hundreds of millions of lives. In this era, long before the concepts of pathogens and infectious diseases were established, ...
Anticoagulation is a critical component in the treatment of cardiovascular diseases. Large randomised controlled trials have ...
International Centre for Circulatory Health, 10th Floor QEQM Wing, St Mary’s Hospital, and Imperial College Paddington and Clinical Pharmacology, NHLI, Imperial College of Science, Technology & ...
In 2017, the British Association for Cardiovascular Prevention and Rehabilitation published its official document detailing standards and core components for cardiovascular prevention and ...
Atrial fibrillation (AF) is the most common arrhythmia and is a leading cause of stroke and heart failure yet often remains undiagnosed. Screening has been proposed to identify asymptomatic AF and ...
Correspondence to: Dr Arend Mosterd Department of Cardiology, Meander Medical Centre, PO Box 1502, 3800 BM Amersfoort, The Netherlands; a.mosterd{at}meandermc.nl If you wish to reuse any or all of ...
Correspondence to Dr José Angel Cabrera, Department of Cardiology, Hospital Universitario Quirón-Madrid, European University of Madrid, Calle de Diego de Velázquez. 28223 Pozuelo de Alarcón (Madrid), ...
Introduction The burden of coronary heart disease (CHD) in the UK is substantial. However, recent trends and associated socioeconomic inequalities are not well studied. We aim to identify and analyse ...
Hypertrophic cardiomyopathy (HCM) is the most frequently cited cause of exercise-related sudden cardiac death (SCD) in young individuals and has claimed the lives of some high-profile athletes. The ...
OBJECTIVE To determine the cardiovascular and coronary risk thresholds at which aspirin for primary prevention of coronary heart disease is safe and worthwhile. DESIGN Meta-analysis of four randomised ...
A 28-year-old man is described with no demonstrable organic heart disease and recurrent paroxysmal attacks of sustained ventricular tachycardia. Lignocaine and ajmaline failed to terminate the first ...
Background The Assessing cardiovascular risk using Scottish Intercollegiate Guidelines Network (ASSIGN) risk score, developed in 2006, is used in Scotland for estimating the 10-year risk of first ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results